Stoke Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Stoke Therapeutics Inc
TickerSTOK
CIK #0001623526
CUSIP86150R107
SectorLife Sciences - Pharmaceutical Preparations
Address3 Preston Court, Bedford, MA 01730
Source [EDGAR]
CIK Filing 2011 - 2025
[0001623526] 10-K
[0001623526] 10-Q
[0001623526] 3
[0001623526] 4
[0001623526] 8-K
[0001623526] D
[0001623526] SC 13D
[0001623526] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Stoke Therapeutics Inc [2025-06-06] 0.0
BlackRock Portfolio Management LLC Stoke Therapeutics Inc [2025-04-15] 0.0
Baker Bros Advisors LP Stoke Therapeutics Inc [2024-11-14] 8.3
BlackRock Inc Stoke Therapeutics Inc [2024-07-08] 10.4
Cowen Financial Products LLC Stoke Therapeutics Inc [2024-02-26] 5.77
Lynx1 Capital Management LP Stoke Therapeutics Inc [2023-11-06] 6.0
Morgan Stanley Stoke Therapeutics Inc [2023-02-10] 6.2
Vanguard Group Inc Stoke Therapeutics Inc [2022-02-10] 5.2
Cowen Financial Products LLC Stoke Therapeutics Inc [2022-01-24] 5.09
Skorpios Trust Stoke Therapeutics Inc [2021-06-30] 0.0
Redmile Group LLC Stoke Therapeutics Inc [2021-02-16] 7.4
FMR LLC Stoke Therapeutics Inc [2021-02-08] 0.0
Gilder Gagnon Howe & Co LLC Stoke Therapeutics Inc [2020-02-14] 5.58
Apple Tree Partners IV LP Stoke Therapeutics Inc [2019-07-01] 51.4
Cormorant Asset Management LP Stoke Therapeutics Inc [2019-07-01] 2.45
RTW Investments LP Stoke Therapeutics Inc [2019-06-28] 10.67
Form 3/4/5 Filer 2011 - 2025
Stoke Therapeutics, Inc.
Kaye Edward M. MD
Allan Jonathan
Ticho Barry
Levin Arthur A
Hoitt Jason
Montrago Trustees Ltd
Blue Horizon Enterprise Ltd
Skorpios Trust
Ezbon International Ltd
Smith Julie
Menzel Garry E
Krainer Adrian R.
Harrison Seth Loring
Burstein Jennifer
Smith Ian F
Tzianabos Arthur
Leggett Thomas
Nash Huw M.
Tulipano Stephen J
ATP Life Science Ventures, L.P.
ATP III GP, Ltd.
Liau Gene
Walker Robin A.
Wong Roderick
RTW Investments LP
Hall Samuel W.
Redmile Group, LLC
Green Jeremy
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2025-06-30] DFND 7,405,833 7,412,982
BlackRock, Inc. [2025-06-30] SOLE 5,726,601 5,924,567
Lynx1 Capital Management LP [2025-06-30] OTR 0 5,404,674
RTW Investments LP [2025-06-30] SOLE 5,123,525 5,123,525
Baker Bros Advisors LP [2025-06-30] SOLE 4,633,838 4,633,838
Redmile Group LLC [2025-06-30] SOLE 4,375,931 4,375,931
Morgan Stanley [2025-06-30] DFND 3,571,975 3,573,976
Skorpios Trust [2025-06-30] SOLE 3,256,181 3,256,181
Toronto Dominion Bank [2025-06-30] DFND 0 3,173,258
Vanguard Group Inc [2025-06-30] SOLE 0 2,865,850
Marshall Wace LLP [2025-06-30] OTR 0 2,300,554
Siren, L.L.C. [2025-06-30] DFND 2,247,347 2,247,347
State Street Corp [2025-06-30] DFND 1,419,626 1,487,156
Goldman Sachs Group Inc [2025-06-30] DFND 1,301,031 1,301,381
Geode Capital Management LLC [2025-06-30] DFND 972,921 972,921
Polar Capital Holdings Plc [2025-06-30] DFND 883,646 883,646
MPM BioImpact LLC [2025-06-30] SOLE 789,698 789,698
Corient Private Wealth LLC [2025-06-30] SOLE 0 659,834
Dimensional Fund Advisors LP [2025-06-30] SOLE 588,847 624,393
Opaleye Management Inc [2025-06-30] SOLE 562,120 562,120
Bank of America Corp /DE/ [2025-06-30] DFND 9,847 548,090
Assenagon Asset Management S.A. [2025-06-30] SOLE 537,973 537,973
Granahan Investment Management LLC [2025-06-30] SOLE 488,143 532,413
DAFNA Capital Management LLC [2025-06-30] SOLE 501,972 501,972
Tang Capital Management LLC [2025-06-30] OTR 0 500,000
Northern Trust Corp [2025-06-30] DFND 417,011 417,011
Erste Asset Management GmbH [2025-06-30] SOLE 396,000 396,000
UBS Group AG [2025-06-30] DFND 352,715 352,715
Charles Schwab Investment Management Inc [2025-06-30] SOLE 340,779 340,779
Cormorant Asset Management LP [2025-06-30] DFND 254,161 254,161
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com